financetom
Business
financetom
/
Business
/
Market Chatter: Brookfield Asset Management Delays Citypoint Tower Sale After Bids Fall Short
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Brookfield Asset Management Delays Citypoint Tower Sale After Bids Fall Short
Jan 3, 2025 11:05 AM

01:33 PM EST, 01/03/2025 (MT Newswires) -- Brookfield Asset Management ( BAM ) has delayed the sale of its Citypoint tower in London after bids failed to meet expectations, forcing the company to extend debt repayments, Reuters reported Friday, citing a source familiar with the situation.

The company had aimed for 500 million British pounds ($621 million) for the 36-story office building, but received offers under 400 million pounds, leading to a halt in the sales process, the source told Reuters, adding that Brookfield could relist Citypoint if the market conditions improve.

Creditors have extended Brookfield's loan repayment deadline for the Citypoint tower to April 20, according to the news outlet.

Brookfield didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 54.79, Change: +0.45, Percent Change: +0.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neurocrine Biosciences Swings to Q1 Adjusted Earnings as Revenue Increases -- Shares Jump Pre-Bell
Neurocrine Biosciences Swings to Q1 Adjusted Earnings as Revenue Increases -- Shares Jump Pre-Bell
May 1, 2024
08:31 AM EDT, 05/01/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) reported Q1 non-GAAP earnings Wednesday of $1.20 per diluted share, swinging from a loss of $0.51 a year earlier. Analysts polled by Capital IQ expected $1.29. Revenue for the quarter ended March 31 was $515.3 million, up from $420.4 million a year earlier. Analysts surveyed by Capital IQ...
Carlyle Group's Q1 Distributable Earnings Rise, Revenue Falls
Carlyle Group's Q1 Distributable Earnings Rise, Revenue Falls
May 1, 2024
08:23 AM EDT, 05/01/2024 (MT Newswires) -- The Carlyle Group ( CG ) reported Q1 distributable earnings Wednesday of $1.01 per diluted share, up from $0.63 a year earlier. Analysts polled by Capital IQ expected $0.94. Total revenue for the quarter ended March 31 was $688.4 million, down from $859.0 million a year earlier. Four analysts surveyed by Capital IQ...
VitalHub Appoints Patrick Mazza as COO, Niels Tofting as Managing Director of North American Operations
VitalHub Appoints Patrick Mazza as COO, Niels Tofting as Managing Director of North American Operations
May 1, 2024
08:29 AM EDT, 05/01/2024 (MT Newswires) -- VitalHub ( VHIBF ) on Wednesday appointed Patrick Mazza as chief operating officer and Niels Tofting as managing director of North American operations. Mazza - who joined VitalHub ( VHIBF ) in June 2022 as executive vice president, performance and operations - has more than 25 years and is tasked with scaling the...
PPL Q1 Adjusted Earnings Increase, Revenue Decreases; Reiterates 2024 Adjusted Profit Guidance
PPL Q1 Adjusted Earnings Increase, Revenue Decreases; Reiterates 2024 Adjusted Profit Guidance
May 1, 2024
08:25 AM EDT, 05/01/2024 (MT Newswires) -- PPL (PPL) reported Q1 adjusted earnings from ongoing operations Wednesday of $0.54 per diluted, up from $0.48 a year earlier. Analysts polled by Capital IQ expected $0.50. Operating revenue for the quarter ended March 31 was $2.30 billion, down from $2.42 billion a year earlier. Two analysts polled by Capital IQ expected $2.16...
Copyright 2023-2026 - www.financetom.com All Rights Reserved